
A May 2026 European Heart Journal study of 112,395 French adults found that people with the highest intake of eight common food preservatives had 10–39% higher hazard ratios for hypertension and 16% higher CVD risk — but the study is observational, and the signal most likely reflects broad ultra-processed food consumption rather than preservatives themselves. The clearest action: cut processed meat, not the preservatives on the label.
| Preservative (E-code) | Role | HR for hypertension (95% CI) |
|---|---|---|
| Potassium sorbate (E202) | Mold inhibitor in dairy, baked goods | 1.39 (1.28–1.50) |
| Citric acid (E330) | Acidulant/preservative in drinks, canned goods | 1.25 (1.16–1.34) |
| Potassium metabisulfite (E224) | Sulfite in wine, dried fruit | 1.16 (1.08–1.25) |
| Sodium nitrite (E250) | Curing agent in processed meats | 1.16 (1.08–1.25) |
| Ascorbic acid (E300) | Antioxidant in processed foods | 1.14 (1.06–1.22) |
| Sodium ascorbate (E301) | Antioxidant in processed meats, beverages | 1.12 (1.04–1.20) |
| Sodium erythorbate (E316) | Antioxidant in processed meats | 1.14 (1.06–1.22) |
| Rosemary extract (E392) | Natural antioxidant in oils, snacks | 1.10 (1.02–1.18) |
"It's important to note that this is an observational study: this means that participants were not randomly allocated to consume more or fewer preservatives. As such we cannot be sure that the people who consumed more preservatives were not different from those who consumed fewer preservatives in ways that affected their risk of hypertension and CVD."
"Consumers should not be concerned by the findings of this study."
"Naturally occurring ascorbic acid and added ascorbic acid — which may be chemically manufactured — may have different impacts on health. Thus, the results observed here for these food additives are not true for natural substances found in fruits and vegetables."
Study label: Observational cohort. The findings are associative, not causal. The full text of the European Heart Journal article was not accessible (Oxford Academic paywall); this article is based on the structured PubMed abstract, a pre-publication conference abstract, the INSERM press release, the Science Media Centre expert reactions, and ESC press materials. Funding and conflict-of-interest disclosures for the full paper could not be verified. Prof. Gunter Kuhnle disclosed prior funding from Mars (flavanol research, 2010–2020), prior EFSA ANS panel membership (2018–2019), and UK Committee on Toxicity membership (2019–2025).
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.